Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06157073
Other study ID # 2023317-12254
Secondary ID NMRR ID-23-03290
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 1, 2024
Est. completion date December 31, 2025

Study information

Verified date November 2023
Source University of Malaya
Contact Dr Muhaimin, MMed
Phone +60173600157
Email muhaimin@um.edu.my
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients presenting to the emergency department (ED) may require breathing support with machines depending on the condition. Throughout the breathing support, the settings on the breathing machines will be tailored to the patient's requirements. These settings are manually adjusted by trained physicians. Currently, there are machines which can automatically change the settings based on real-time specific information obtained from the patient. This study aims to compare the use of machines which require manual adjustments (open-loop conventional ventilators) and machines which can automatically change the settings (closed-loop automated ventilators). Patients will be carefully selected to ensure no harm is caused whilst delivering the best care. This study will look into the duration when patients are receiving optimum settings and levels of oxygen and carbon dioxide in the blood. The outcomes of this study would allow us to identify methods to improve patient care.


Description:

Invasive mechanical ventilation is a lifesaving intervention for patients with respiratory failure in the emergency department (ED). Recent technological advancements have introduced closed-loop automated ventilators as a potential alternative to open-loop conventional ventilators. However, the efficacy and safety of closed-loop automated ventilators in the emergency setting remains understudied. This research aims to evaluate the efficacy and safety of closed-loop automated ventilator compared to open-loop conventional ventilator in intubated and ventilated patients in the ED. A randomized controlled trial will be conducted in an ED of a tertiary university-affiliated hospital. Eligible patients are 18 years or older, decision made by treating physicians to intubate and mechanically ventilate. Some of exclusion criteria are pregnancy, heart failure, metabolic acidosis, circulatory shock, life-threatening asthma and morbid obesity. The primary measure of efficacy is the duration of ventilation within a predefined range of acceptable respiratory parameters between automated and conventional ventilation. Secondary outcome measures are; number of manual adjustments required to attain targeted settings in automated and conventional ventilators, PaO2/FiO2 ratio (PF ratio), arterial blood gas results, vital signs, breath-by-breath analysis, and rate of ventilator dyssynchrony. The ventilator used in the intervention arm is the closed-loop automated ventilator Hamilton C6s INTELLIVENT-ASV (Hamilton Medical AG, Switzerland). Hamilton C1 ASV is chosen as the open-loop conventional comparator as it is similar to Hamilton C6s INTELLIVENT-ASV, without the INTELLIVENT software. Based on Lellouche et al, the calculated total sample size with a dropout rate of 10% is 132. The data is analysed based on the intention-to-treat (ITT) and per-protocol (PP) principles. The primary endpoint measurements are reported as areas under the curves (AUC) within the predefined range of acceptable respiratory parameters. Between-group differences in continuous variables are analysed using independent t-test or Mann-Whitney U test. Between-group differences in categorical variables are analysed using chi-square test.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 132
Est. completion date December 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Decision made by treating physicians to intubate and mechanically ventilate Exclusion Criteria: 1. Suspected or confirmed pregnancy. 2. Known right ventricular heart failure upon assessment for recruitment. 3. Severe metabolic acidosis upon intubation (pH <7.2 or bicarbonate <12 mmol/L) 4. Circulatory shock requiring noradrenaline more than 0.5 mcg/kg/min upon assessment for recruitment. 5. Severe or acute life-threatening asthma. 6. Patients with chest wall deformities that would affect ventilation (e.g. severe kyphoscoliosis, diaphragmatic hernia, flail chest, trauma, pectus excavatum or carinatum, ankylosing spondylitis 7. Patients with previous lobectomy or pneumonectomy. 8. Patients with pneumothorax or other condition that requires chest drainage tube. 9. Patients with body mass index > 40 kg/m2. 10. Manufacturer's contraindications: - Difference in oxygen saturation between pulse oximetry (SpO2) and arterial sample (SaO2) of more than 5% (due to unreliable sensor). - Difference in carbon dioxide level between end-tidal sensor (ETCO2) and arterial sample (PaCO2) of more than 5 mm Hg (due to unreliable sensor). - Known pneumothorax and bronchopulmonary fistula upon assessment for recruitment. 11. Participation in another interventional trial. 12. Do-not-attempt-resuscitation (DNAR) order.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Closed-loop ventilator
Fully automated closed-loop ventilator using the INTELLIVENT software
Open-loop ventilator
Conventional closed-loop ventilator with manual adjustments by the physician in charge

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Malaya

References & Publications (6)

Angotti LB, Richards JB, Fisher DF, Sankoff JD, Seigel TA, Al Ashry HS, Wilcox SR. Duration of Mechanical Ventilation in the Emergency Department. West J Emerg Med. 2017 Aug;18(5):972-979. doi: 10.5811/westjem.2017.5.34099. Epub 2017 Jul 11. — View Citation

Arnal JM, Garnero A, Novonti D, Demory D, Ducros L, Berric A, Donati S, Corno G, Jaber S, Durand-Gasselin J. Feasibility study on full closed-loop control ventilation (IntelliVent-ASV) in ICU patients with acute respiratory failure: a prospective observational comparative study. Crit Care. 2013 Sep 11;17(5):R196. doi: 10.1186/cc12890. — View Citation

Chelly J, Mazerand S, Jochmans S, Weyer CM, Pourcine F, Ellrodt O, Thieulot-Rolin N, Serbource-Goguel J, Sy O, Vong LVP, Monchi M. Automated vs. conventional ventilation in the ICU: a randomized controlled crossover trial comparing blood oxygen saturation during daily nursing procedures (I-NURSING). Crit Care. 2020 Jul 22;24(1):453. doi: 10.1186/s13054-020-03155-3. — View Citation

Clavieras N, Wysocki M, Coisel Y, Galia F, Conseil M, Chanques G, Jung B, Arnal JM, Matecki S, Molinari N, Jaber S. Prospective randomized crossover study of a new closed-loop control system versus pressure support during weaning from mechanical ventilation. Anesthesiology. 2013 Sep;119(3):631-41. doi: 10.1097/ALN.0b013e3182952608. — View Citation

Lellouche F, Bouchard PA, Simard S, L'Her E, Wysocki M. Evaluation of fully automated ventilation: a randomized controlled study in post-cardiac surgery patients. Intensive Care Med. 2013 Mar;39(3):463-71. doi: 10.1007/s00134-012-2799-2. Epub 2013 Jan 22. — View Citation

Savioli G, Ceresa IF, Gri N, Bavestrello Piccini G, Longhitano Y, Zanza C, Piccioni A, Esposito C, Ricevuti G, Bressan MA. Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions. J Pers Med. 2022 Feb 14;12(2):279. doi: 10.3390/jpm12020279. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of ventilation within a predefined range of acceptable respiratory parameters Duration of ventilation (in minutes) within predefined acceptable tidal volume (TV), plateau pressure, EtCO2 and SpO2 Every 30 seconds for 240 minutes
Secondary Manual adjustments of ventilator settings Frequency of manual adjustments of ventilator settings and the parameters requiring adjustments Any time the manual adjustment is performed throughout the 4-hour study period
Secondary Physiological data - blood pressure Patient's blood pressure in mmHg Mean hourly for 4 hours
Secondary Physiological data - respiratory rate Patient's respiratory rate in breaths per minute Mean hourly for 4 hours
Secondary Physiological data - heart rate Patient's heart rate in beats per minute Mean hourly for 4 hours
Secondary Biochemical data - pH Arterial pH levels Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Secondary Biochemical data - CO2 and O2 Arterial partial pressure of carbon dioxide and oxygen in mmHg Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Secondary Biochemical data - bicarbonate Arterial bicarbonate levels in mmol/L Upon intubation, at 1-hour, 2-hour, 3-hour and 4-hour
Secondary Patient outcome - mechanical ventilation Duration of mechanical ventilation Assessed from time of intubation to time of successful extubation or death from any cause, whichever came first, assessed up to 28 days
Secondary Patient outcome - LOS ED Length of stay in emergency department Assessed from time of triage to time patient leaves ED or death, whichever comes first, up to 7 days
Secondary Patient outcome - LOS ICU Length of intensive care unit stay Assessed from time of admission into the ICU to time of transfer to general ward or death, whichever comes first up to 28 days
Secondary Patient outcome - LOS hospital Length of hospital stay Assessed from time of triage in ED to time of discharge or in-hospital death, whichever comes first up to 28 days
Secondary Mortality rate Number and percentage of deaths At 14 and 28 days after recruitment
Secondary Number of patients developing ARDS and pneumothorax Development of complications (pneumothorax, ARDS) during study and throughout admission At anytime within the 4-hour intervention or upon discharge or diagnosis of complications
Secondary Ventilator data - airway pressures Ventilator parameters: mean and peak airway pressures in cmH20 Every 30 seconds for 240 minutes
Secondary Ventilator data - FiO2 Ventilator parameters: fraction of inspired oxygen (FiO2) Every 30 seconds for 240 minutes
See also
  Status Clinical Trial Phase
Completed NCT04435613 - Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients N/A
Enrolling by invitation NCT05020210 - Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
Completed NCT04468971 - REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia Phase 1
Completed NCT04505592 - Tenecteplase in Patients With COVID-19 Phase 2
Completed NCT04493242 - Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS Phase 2
Withdrawn NCT04909879 - Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome Phase 2
Completed NCT02265198 - Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome N/A
Completed NCT01949272 - Optimization of PEEP for Alveolar Recruitment in ARDS N/A
Not yet recruiting NCT01668368 - Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance N/A
Completed NCT01881061 - Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit N/A
Completed NCT00808691 - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit N/A
Completed NCT05035589 - The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
Recruiting NCT04764032 - Right Ventricular Dysfunction in Ventilated Patients With COVID-19
Completed NCT04556513 - Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Recruiting NCT06036056 - NMR Based Metabolomics Kinetics in ARDS Patients
Recruiting NCT04503876 - Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress Syndrome N/A
Recruiting NCT04643691 - Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS Phase 2
Completed NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections N/A
Not yet recruiting NCT05341687 - Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Recruiting NCT05056090 - Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome. N/A